Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hutchmed China Ltd ADR
(NQ:
HCM
)
17.45
-0.31 (-1.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hutchmed China Ltd ADR
< Previous
1
2
3
4
5
6
7
8
Next >
Which Chinese Stocks Could Get Delisted? 6 Companies to Watch.
March 25, 2022
Today, news that Weibo has been added to the SEC's list of at-risk companies for delisting has investors selling Chinese stocks in a big way.
Via
InvestorPlace
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
Chinese Stock Delisting News: Why Are BABA, DIDI, IQ, YUMC, ACMR, BGNE and ZLAB Down Today?
March 11, 2022
Chinese stock delisting news today has several big names in the country seeing their shares slip on fears they could be next.
Via
InvestorPlace
Stocks That Hit 52-Week Highs On Thursday
July 29, 2021
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new...
Via
Benzinga
What's Going On With Zai Lab, Hutchmed, BeiGene Shares Today
March 11, 2022
Three of the most major drugmakers with roots in China, Zai Lab Ltd (NASDAQ: ZLAB), BeiGene Ltd (NASDAQ: BGNE), and Hutchmed China Ltd (NASDAQ: HCM...
Via
Benzinga
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
March 11, 2022
Key Takeaways U.S. securities regulator says Hutchmed is one of five Chinese companies in danger of delisting, a week after company announced the retirement of its longtime CEO...
Via
Benzinga
Chinese Stocks Are Falling: What's Going On?
March 10, 2022
Shares of multiple Chinese companies are trading lower Thursday following reports the U.S. Securities and Exchange Commision has identified multiple US-listed ADRs as...
Via
Benzinga
Why BeiGene — And 2 Other China-Based Biotechs — Are In Trouble
March 10, 2022
The SEC is calling out a several stocks for non-compliance. Could they face delisting?
Via
Investor's Business Daily
Hutchmed Clocks Over 50% Jump In FY21 Sales Boosted By Three Oncology Drugs, Announces CEO Transition
March 03, 2022
Hutchmed (China) Limited (NASDAQ: HCM) reported FY21 sales of $356.1 million, up 56% Y/Y, driven by commercial progress on three in-house developed oncology drugs...
Via
Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...
Via
Benzinga
Week In Review: Biopharma Deals Slow During Chinese New Year Week
February 05, 2022
Amid a slow week, Shanghai's HanBio Therapeutics raised $40 million in a Series A financing to advance its innovative biologic products. HanBio is an early R&D company that was incubated by Sunshine...
Via
Talk Markets
58 Biggest Movers From Yesterday
December 17, 2021
Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price...
Via
Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
December 16, 2021
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce...
Via
Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
December 16, 2021
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO...
Via
Benzinga
61 Biggest Movers From Yesterday
November 23, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...
Via
Benzinga
Exposures
Product Safety
40 Stocks Moving In Monday's Mid-Day Session
November 22, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...
Via
Benzinga
Exposures
COVID-19
20 Stocks Moving in Monday's Pre-Market Session
November 22, 2021
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...
Via
Benzinga
Week In Review: Broncus Stages $200 Million Hong Kong IPO For Pulmonary Devices
September 25, 2021
Broncus Holding, a Hangzhou pulmonary medical device company, completed a $200 million IPO on the Hong Kong exchange that valued the company at nearly $1.3 billion. The IPO was priced at the top end of...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
HUTCHMED's Lymphoma Candidate Secures Breakthrough Tag In China
September 13, 2021
The Center for Drug Evaluation of China's National Medical Products Administration has granted Breakthrough Therapy Designation to HUTCHMED (China) Limited...
Via
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
August 14, 2021
Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to...
Via
Talk Markets
Epizyme Stock Gains On Potential $310M Pact With HUTCHMED For Cancer-Focused Tazverik In Greater China
August 09, 2021
Epizyme Inc (NASDAQ: EPZM) and HUTCHMED (China) Limited (NASDAQ: HCM) have collaborated to research, develop, manufacture, and commercialize Tazverik (...
Via
Benzinga
Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China
August 08, 2021
From
Epizyme, Inc.
Via
Business Wire
Hutchison China MediTech Ltd (HCM) Q2 2021 Earnings Call Transcript
July 28, 2021
HCM earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 28, 2021
Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market session. The company's market cap stands at $...
Via
Benzinga
62 Biggest Movers From Yesterday
July 29, 2021
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Hutchmed Stock Gains On Kick Starting Mid-Stage Gastric Cancer Trial With AstraZeneca's Orpathys
July 28, 2021
HUTCHMED (China) Limited (NASDAQ: HCM) and AstraZeneca Plc (NASDAQ: AZN) have initiated a Phase 2 study of Orpathys (savolitinib) in patients with...
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
July 28, 2021
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the...
Via
Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
July 28, 2021
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares rose 38.2% to $2.10 in pre-market trading. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 16, 2021
Gainers Moderna (NASDAQ:MRNA) stock increased by 7.67% to $279.6 during Friday's pre-market session. The company's market cap stands at $112.2 billion. Eton...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.